<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: A 54-year-old woman presented with a 3-week history of <z:mp ids='MP_0002899'>fatigue</z:mp> and with <z:hpo ids='HP_0000952'>jaundice</z:hpo> that began 2 days before admission </plain></SENT>
<SENT sid="1" pm="."><plain>She had been undergoing treatment with flavoxate for <z:hpo ids='HP_0000020'>urinary incontinence</z:hpo> (for 2 months before admission) and with tibolone for <z:e sem="disease" ids="C0025319" disease_type="Disease or Syndrome" abbrv="">climacteric syndrome</z:e> (for 6 months before admission) </plain></SENT>
<SENT sid="2" pm="."><plain>Laboratory tests revealed elevated concentrations of aminotransferases, <z:chebi fb="0" ids="16990">bilirubin</z:chebi>, gamma-glutamyltransferase and alkaline phosphatase </plain></SENT>
<SENT sid="3" pm="."><plain>Liver biopsy revealed histological evidence of <z:hpo ids='HP_0011011'>subacute</z:hpo>, drug-induced liver damage </plain></SENT>
<SENT sid="4" pm="."><plain>INVESTIGATIONS: Physical examination, liver function tests, serology tests, autoantibody tests, genetic analysis of the TATA box of the UGT1A1 gene, ultrasonography and CT scan; MRI cholangiography; liver biopsy </plain></SENT>
<SENT sid="5" pm="."><plain>DIAGNOSIS: Drug-related <z:hpo ids='HP_0012115'>hepatitis</z:hpo> in a patient with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>MANAGEMENT: Flavoxate and tibolone were discontinued </plain></SENT>
<SENT sid="7" pm="."><plain>Liver function test results improved progressively and normalized after almost 2 months </plain></SENT>
</text></document>